Hamaguchi, S., Zafar, M. A., Cammer, M. & Weiser, J. N. Capsule Prolongs Survival of Streptococcus pneumoniae during Starvation. Infect. Immun. 86, 00802–17 (2018).
Li, Z. J. et al. Etiological and epidemiological features of acute respiratory infections in China. Nat. Commun. 12, (2021).
Troeger, C. et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis. 18, 1191–1210 (2018).
Kaur, R., Pham, M., Yu, K. O. A. & Pichichero, M. E. Rising Pneumococcal Antibiotic Resistance in the Post-13-Valent Pneumococcal Conjugate Vaccine Era in Pediatric Isolates From a Primary Care Setting. Clin. Infect. Dis. 72, 797–805 (2021).
Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).
Pereira, J. M., Xu, S. Y., Leong, J. M. & Sousa, S. The Yin and Yang of Pneumolysin During Pneumococcal Infection. Front. Immunol. 13, 878244 (2022).
Jinno, A., Hayashida, A., Jenkinson, H. F. & Park, P. W. Syndecan-1 Promotes Streptococcus pneumoniae Corneal Infection by Facilitating the Assembly of Adhesive Fibronectin Fibrils. Mbio. 11, 01907–20 (2020).
Jennert, F. et al. Hydrogen Peroxide Is Responsible for the Cytotoxic Effects of Streptococcus pneumoniae on Primary Microglia in the Absence of Pneumolysin. J. Innate Immun. 16, 248–261 (2024).
Redanz, S. et al. Pyruvate secretion by oral streptococci modulates hydrogen peroxide dependent antagonism. Isme J. 14, 1074–1088 (2020).
An, H. R. et al. Functional vulnerability of liver macrophages to capsules defines virulence of blood-borne bacteria. J. Exp. Med. 219, 20212032 (2022).
Kadioglu, A., Weiser, J. N., Paton, J. C. & Andrew, P. W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol 6, 288–301 (2008).
James, C., Paton, Claudia & Trappetti. Streptococcus pneumoniae Capsular Polysaccharide. Microbiol. spectrum (2019).
Subramanian, K., Henriques-Normark, B. & Normark, S. Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: From nasopharyngeal colonizer to intracellular pathogen. Cell Microbiol. 21, e13077 (2019).
Nelson, A. L. et al. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect. Immun. 75, 83–90 (2007).
Gil, E., Noursadeghi, M. & Brown, J. S. Streptococcus pneumoniae interactions with the complement system. Front. Cell Infect. Mi 12, 929483 (2022).
Syed, S., Viazmina, L., Mager, R., Meri, S. & Haapasalo, K. Streptococci and the complement system: interplay during infection, inflammation and autoimmunity. Febs Lett. 594, 2570–2585 (2020).
Brissac, T. et al. Capsule Promotes Intracellular Survival and Vascular Endothelial Cell Translocation during Invasive Pneumococcal Disease. Mbio 12, e0251621 (2021).
Bruce, K. E., Rued, B. E., Tsui, H. C. T. & Winkler, M. E. The Opp (AmiACDEF) Oligopeptide Transporter Mediates Resistance of Serotype 2 Streptococcus pneumoniae D39 to Killing by Chemokine CXCL10 and Other Antimicrobial Peptides. J. Bacteriol. 200, e00745–17 (2018).
Thompson, C. D. et al. Oligopeptide Transporters of Nonencapsulated Streptococcus pneumoniae Regulate CbpAC and PspA Expression and Reduce Complement-Mediated Clearance. Mbio 1, e0332522 (2023).
Wartha, F. et al. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol 9, 1162–1171 (2007).
de Vos, A. F. et al. The Polysaccharide Capsule of Streptococcus pneumonia Partially Impedes MyD88-Mediated Immunity during Pneumonia in Mice. Plos One 10, e0118181 (2015).
Sari, R. F., Fadilah, F., Maladan, Y., Sarassari, R. & Safari, D. A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of Streptococcus pneumonia capsular polysaccharide. Clin. Exp. Vaccin. Res 13, 91–104 (2024).
Puri, M. & Sharma, D. Antibacterial activity of stevioside towards food-borne pathogenic bacteria. Eng. Life Sci. 11, 326–329 (2011).
Shainheit, M. G., Muié, M. & Camilli, A. The Core Promoter of the Capsule Operon of Streptococcus pneumoniae Is Necessary for Colonization and Invasive Disease. Infect. Immun. 82, 694–705 (2014).
Wen, Z. S. et al. Sequence Elements Upstream of the Core Promoter Are Necessary for Full Transcription of the Capsule Gene Operon in Streptococcus pneumoniae Strain D39. Infect. Immun. 83, 1957–1972 (2015).
Troxler, L. J. et al. Carbon source regulates polysaccharide capsule biosynthesis in Streptococcus pneumoniae. J. Biol. Chem. 294, 17224–17238 (2019).
Im, H. et al. Targeting NAD plus regeneration enhances antibiotic susceptibility of Streptococcus pneumoniae during invasive disease. Plos Biol. 21, e3002020 (2023).
Hirschmann, S. et al. The Two-Component System 09 Regulates Pneumococcal Carbohydrate Metabolism and Capsule Expression. Microorganisms 9, 30468 (2021).
Hoskins, J. et al. Genome of the bacterium Streptococcus pneumoniae strain R6. J. Bacteriol. 183, 5709–5717 (2001).
Su, Y. B. et al. Pyruvate cycle increases aminoglycoside efficacy and provides respiratory energy in bacteria (vol 115, pg E1578, 2018). Proc. Natl. Acad Sci. USA 116, 2774–2775 (2019).
Gaspar, P., Al-Bayati, F. A. Y., Andrew, P. W., Neves, A. R. & Yesilkaya, H. Lactate Dehydro2genase Is the Key Enzyme for Pneumococcal Pyruvate Metabolism and Pneumococcal Survival in Blood. Infect. Immun. 82, 5099–5109 (2014).
Echlin, H., Frank, M., Rock, C. & Rosch, J. W. Role of the pyruvate metabolic network on carbohydrate metabolism and virulence in Streptococcus pneumoniae. Mol. Microbiol 114, 536–552 (2020).
Rivera-Lugo, R. et al. Listeria monocytogenes requires cellular respiration for NAD regeneration and pathogenesis. Elife 11, e75424 (2022).
Rodionova, I. A. et al. Metabolic and Bactericidal Effects of Targeted Suppression of NadD and NadE Enzymes in Mycobacteria. Mbio 5, e00747–13 (2014).
Im, H. et al. Anatomical Site-Specific Carbohydrate Availability Impacts Streptococcus pneumoniae Virulence and Fitness during Colonization and Disease. Infect. Immun. 90, e0045121 (2022).
Kanojiya, P., Joshi, R. & Saroj, S. D. The source of carbon and nitrogen differentially affects the survival of Neisseria meningitidis in macrophages and epithelial cells. Arch. Microbiol. 204, 404 (2022).
Ejaz, H. et al. The Rising Tide of Antibiotic Resistance: A Study on Extended-Spectrum Beta-Lactamase and Carbapenem-Resistant and. J. Clin. Lab Anal. 38, e25081 (2024).
Llobet, E., Tomás, J. M. & Bengoechea, J. A. Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiol-Sgm 154, 3877–3886 (2008).
Al-Farsi, H. M. et al. Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant Klebsiella pneumoniae With mgrB Insertions. Front, Microbiol. 10, 2632 (2019).
Hyams, C., Camberlein, E., Cohen, J. M., Bax, K. & Brown, J. S. The Streptococcus pneumoniae Capsule Inhibits Complement Activity and Neutrophil Phagocytosis by Multiple Mechanisms. Infect. Immun. 78, 704–715 (2010).
Gupta, R. et al. Deletion of arcD in Streptococcus pneumoniae D39 Impairs Its Capsule and Attenuates Virulence. Infect. Immun. 81, 3903–3911 (2013).
Hupp, S. et al. Pneumolysin and the bacterial capsule of Streptococcus pneumoniae cooperatively inhibit taxis and motility of microglia. J. Neuroinflamm. 16, 105 (2019).
Wand, M. E., McCowen, J. W. I., Nugent, P. G. & Sutton, J. M. Complex interactions of Klebsiella pneumoniae with the host immune system in a infection model. J. Med Microbiol 62, 1790–1798 (2013).
Alavala, S. et al. Stevioside, a diterpenoid glycoside, shows anti-inflammatory property against Dextran Sulphate Sodium-induced ulcerative colitis in mice. Eur. J. Pharm. 855, 192–201 (2019).
Roberts, A. & Renwick, A. G. Comparative toxicokinetics and metabolism of rebaudioside A, stevioside, and steviol in rats. Food Chem. Toxicol. 46, S31–S39 (2008).
Wheeler, A. et al. Pharmacokinetics of rebaudioside A and stevioside after single oral doses in healthy men. Food Chem. Toxicol. 46, S54–S60 (2008).
Paulo, A. C., Lanca, J., Almeida, S. T., Hilty, M. & Sá-Leao, R. The upper respiratory tract microbiota of healthy adults is affected by Streptococcus pneumoniae carriage, smoking habits, and contact with children. Microbiome 11, 199 (2023).
Gao, Z. et al. Analysis of coexisting pathogens in nasopharyngeal swabs from COVID-19. Front. Cell Infect. Microbiol. 13, 1140548 (2023).
Hoque, M. N. et al. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis. Microb. Pathogenesis 156, 104941 (2021).
Zhu, X. J. et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 285, (2020).
Lemma, M. et al. Streptococcus pneumoniae Nasopharyngeal Carriage among PCV-10-Vaccinated HIV-1-Infected Children with Maintained Serological Memory in Ethiopia. Pathogens 9, 9030159 (2020).
Obolski, U. et al. Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of. Streptococcus pneumoniae. Proc Natl Acad. Sci. USA 115, 3102–3107 (2018).
Davies, N. G., Flasche, S., Jit, M. & Atkins, K. E. Modeling the effect of vaccination on selection for antibiotic resistance in Streptococcus pneumoniae. Sci. Transl. Med. 13, aaz8690 (2021).
Dickey, S. W., Cheung, G. Y. C. & Otto, M. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat. Rev. Drug Discov. 16, 457–471 (2017).
Minns, D. et al. The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation. Nat. Commun. 12, 1285 (2021).
Fang, F. C. Antimicrobial Actions of Reactive Oxygen Species. Mbio 2, 00141-11 (2011).
Mike, L. A. et al. A systematic analysis of hypermucoviscosity and capsule reveals distinct and overlapping genes that impact Klebsiella pneumoniae fitness. Plos Pathog. 17, e1009376 (2021).
Wang, L. J., et al. Two-Component Response Regulator OmpR Regulates Mucoviscosity through Energy Metabolism in Klebsiella pneumoniae. Microbiol. Spectrum 11, e0054423 (2023).
Paton, J. C. & Trappetti, C. Streptococcus pneumoniae Capsular Polysaccharide. Microbiol. Spectrum 7, gpp3–0019 (2019).
Su, T. et al. Decoding capsule synthesis in. Streptococcus pneumoniae Fems Microbiol. Rev. 45, fuaa067 (2021).
Ayoola, M. B. et al. Polyamine Synthesis Effects Capsule Expression by Reduction of Precursors in Streptococcus pneumoniae. Front. Microbiol. 10, 1996 (2019).
Ventura, C. L., Cartee, R. T., Forsee, W. T. & Yother, J. Control of capsular polysaccharide chain length by UDP-sugar substrate concentrations in Streptococcus pneumoniae. Mol. Microbiol. 61, 723–733 (2006).
Wang, T. T. et al. Kaempferol-Driven Inhibition of Listeriolysin O Pore Formation and Inflammation Suppresses Listeria monocytogenes Infection. Microbiol. Spectrum 10, e0181022 (2022).
Wang, T. T. et al. Discovery of Kaempferol, a Novel ADAM10 Inhibitor, as a Potential Treatment for Staphylococcus aureus Infection. Eng.-Prc 28, 206–221 (2023).
Cuesta, G., Suarez, N., Bessio, M. I., Ferreira, F. & Massaldi, H. Quantitative determination of pneumococcal capsular polysaccharide serotype 14 using a modification of phenol-sulfuric acid method. J. Microbiol Meth 52, 69–73 (2003).
Eichner, H. et al. RNA thermosensors facilitate Streptococcus pneumoniae and immune evasion. Plos Pathog. 17, e1009513 (2021).
George, J. L., Agbavor, C., Cabo, L. F. & Cahoon, L. A. Streptococcus pneumoniae secretion chaperones PrsA, SlrA, and HtrA are required for competence, antibiotic resistance, colonization, and invasive disease. Infect. Immun. 92, e0049023 (2024).
Echlin, H., Frank, M. W., Iverson, A., Chang, T. C. & Rosch, J. W. Pyruvate Oxidase as a Critical Link between Metabolism and Capsule Biosynthesis in Streptococcus pneumoniae. Plos Pathog. 12, e1005951 (2016).
Hsieh, P. F., Lin, H. H., Lin, T. L. & Wang, J. T. CadC Regulates and Operons in Response to Gastrointestinal Stresses and Enhances Intestinal Colonization of Klebsiella pneumoniae. J. Infect. Dis. 202, 52–64 (2010).
Martins, W. M. B. S. et al. Effective phage cocktail combat rising Incid. extensively drug-resistant. Klebsiella pneumoniae sequence type 16 Emerg. microbes Infect. 11, 1015–1023 (2022).
Wand, M. E., Müller, C. M., Titball, R. W. & Michell, S. L. Macrophage and Galleria mellonella infection models reflect the virulence of naturally occurring isolates of B. pseudomallei, B. thailandensis and B. Bmc Microbiol. 11, 11 (2011).
